Related Experiment Videos
Research note: immunity to Eimeria in broilers reared on nicarbazin and salinomycin
1Department of Animal and Poultry Sciences, University of Arkansas, Fayetteville 72701.
Poultry Science
|March 1, 1992
Summary
Broiler chickens developed partial immunity to Eimeria species after medication. Immunity varied by Eimeria species and farm, indicating incomplete protection from coccidiosis.
Area of Science:
- Poultry Science
- Veterinary Parasitology
- Animal Health
Background:
- Coccidiosis, caused by Eimeria parasites, is a significant concern in broiler production.
- Shuttle programs using anticoccidial drugs like nicarbazin and salinomycin are common for disease control.
- Assessing the development of host immunity is crucial for sustainable parasite management.
Purpose of the Study:
- To evaluate the development of immunity to Eimeria species in broiler chickens.
- To determine the efficacy of a drug shuttle program in inducing protective immunity.
- To compare immunity levels against different Eimeria species across two commercial farms.
Main Methods:
- Monitoring oocyst incidence in litter from two broiler farms over 8 weeks.
- Administering a shuttle program with nicarbazin (0-21 days) and salinomycin (21-44 days).
- Challenging birds with three Eimeria species (E. acervulina, E. maxima, E. tenella) to assess immunity via weight gain and oocyst production.
Main Results:
- Oocysts of at least three Eimeria species were detected in low numbers in the litter.
- Birds from both farms demonstrated immunity to Eimeria acervulina and Eimeria maxima, evidenced by weight gain.
- Incomplete immunity was observed, as indicated by oocyst shedding, particularly against E. acervulina and E. maxima.
- One farm exhibited immunity to Eimeria tenella, while the other remained susceptible.
Conclusions:
- The anticoccidial drug shuttle program conferred partial immunity against key Eimeria species in broiler chickens.
- Immunity levels varied significantly between different Eimeria species and between the two farms studied.
- Further research is needed to optimize drug programs for complete and consistent immunity against coccidiosis.